Please try another search
Proactive Investors - AstraZeneca PLC (LON:AZN) has been upgraded by a leading investment bank following guidance on the company's dividend policy and a more positive earnings outlook. Deutsche Bank ...
(Reuters) -AstraZeneca shareholders on Thursday approved a 2024 pay policy which will boost CEO Pascal Soriot's remuneration to as much as 18.9 million pounds ($23.7 million) this year, but over a...
WASHINGTON D.C. - The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Enhertu for the treatment of adult patients with unresectable or metastatic HER2-positive solid tumors...
LONDON - AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo have received U.S. Food and Drug Administration (FDA) acceptance for a Biologics License Application (BLA) for their drug datopotamab deruxtecan...
TOKYO - AstraZeneca (NASDAQ:AZN), in partnership with Sanofi (EPA:SASY) (NASDAQ:SNY), has announced that its long-acting monoclonal antibody, Beyfortus (nirsevimab), has received approval from the...
TOKYO - AstraZeneca (NASDAQ:AZN)'s Truqap, in combination with Faslodex, has received approval in Japan for the treatment of certain advanced breast cancers, marking a significant advancement in the...
In a significant development, the legal battle between Puma Biotechnology Inc. (NASDAQ: NASDAQ:PBYI) and AstraZeneca (NASDAQ: NASDAQ:AZN) over alleged patent infringement has seen recent court...
Proactive Investors - Blue-chip index adds seven points to 7,729 AstraZeneca (NASDAQ:AZN) snaps up Fusion Pharma Unilever (LON:ULVR) splits out ice cream business Pfizer upsizes Haleon share...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review